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to evnhrate and 
etic stimuktron: dnri 
muhtion resulted In 
n or hawt rate vu 
thetic nervous system influences on the heart rate may 
ifest by direct neural stimulation of the sinus node or by 
a-adrenergic agonists. Heart rate 
developed as 8 tool to evaluate 
the heart (1,2). Frequency domain 
ral) analysis, in particular, has allowed i entifica- 
tion of component frequencies of the heart rate spectrum and 
has been considered a potential method to identify and 
quantify the effects of both the sympathetic and parasympa- 
thetic nervous systemson the heart (2-5). The power in the low 
frequency band, the percent power in the low frequency band 
and the ratio of low to high frequency power have been 
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ability, but kta+idren 
Mci~ility over the three re- 
ueacy domain variables dem~nst~t~ fair to 
(J Am Cdl Cordial ~9~;24:1~2-90) 
suggested to indicate the level of sympathetic tone or sympa- 
thovagal balance (W-9). These observations are based pri- 
marily on studies that have augmented sympathetic tone with 
upright tilt or with pharmacologic agents that lower the blood 
pressure; an increase in the relevant index of heart rate 
variability that is prevented by administration of a beta- 
adrenergic blocker implies that these measures may be useful 
in evaluation of sympathetic tone. Of note, the maneuvers 
tested predominantly increase sympathetic neural activity, with 
no significant effect on circulating epinephrine (6,lO). 
Muscle sympathetic neural activity has been shown to have 
a spectral peak in the low-frequency range (6), perhaps 
accounting for the observed heart rate variability at this 
frequency. It is not known whether sympathetic stimulation 
with circulating eatecholamines also results in heart rate 
variability at this frequency. Because heart rate variability 
analysis has been applied to clinical populations of patients 
(such as those with congestive heart failure) who may have an 
increase in circulating catecholamines (1 l-13), this question 
must be addressed. Thus, the purpose of this study was to 
evaluate and compare the effects of physiologic and pharma- 
cologic adrenergic stimulation on the time and frequency 
domain indexes of heart rate variability. 
07351097/94/$7.00 
JACC W. 24, No. 4 
October 1994zlOK2-90 
AHMEDETAL 
SYMPAT~ETICEFFE~SONHEARTRATEVARIABILi17( 1083 
28.5 4.8 years, ange 22 to 38) were 
ption for 24 h before the study. No 
iabetes mellitus, hypertension, syn- 
disease. All subjects bad  normal 
bitter, informed consent was ob- 
ter in the ~lori~i~lg after an overnight fast. An 
indwelling intravenous catheter was placed in the forearm, 
througl~ which normal saline solution was infused at 30 ml/h. 
Subjects were attached to a cardiac monitor and an automated 
blood pressure device (Accutracker, arquette Electronics). 
In male patients, the chest hair was shaved as needed for 
proper electrode attachment. The ECG data were recorded on 
a Corazonix Computer System (Predictor I series 6.0) using an 
X, Y and Z lead system. The EC6 recordings were made at a 
sampling frequency of 1,000 Hz and stored on an optical disk 
for subsequent analysis. All recordings were made in 5-min 
esign. The study was designed to evaluate the 
effects of beta-adrenergic stimulation and blockade on heart 
rate variability. Heart rate variability was evaluated in each 
subject during rest conditions and after a total of six interven- 
tions. Four different sympathetic stimuli were valuated. Up- 
right tilt and exercise were selected as standard physiologic 
maneuvers that enhance adrencrgic tone. Isoprotel,enol infu- 
sion was chosen as a test condition to evaluate the effects of 
circulating catecholamines, particularly pure beta-adrcnergic 
stimulation, on the heart rate variability. Finally, epinephrine 
infusion was also tested to determine the effects of a naturally 
occurring circulating catecholamine. Assessment of the effects 
of beta-adrenergic and combined beta-adrcnzrgic and para- 
sympathetic blockade was performed by administration of 
propranolol and atropine (14). 
Baseline. Subjects were allowed to rest comfortably in the 
supine position in a quiet room with dim lights. After 15 min ?f 
rest, four baseline 5-min recordings were obtained. 
Sympathetic stimulation. Tik Brfore tilt, after -30 min 
of supine rest, blood was withdrawn by means of the indwelling 
intravenous catheter for measurement of plasma catechol- 
amine levels (n = 13; samples inadequate from one subject). 
Subjects were then tilted to 70” on an electrically driven tilt 
table with a foot support while the heart rate and blood 
pressure were monitored. After 5 min of tilt, three ECG 
recordings were made during tilt. Premature termination of 
the tile test was required in four subjects because of nausea or 
lightheadedness, or both. However, at least one complete 
recording was obtained in all but one subject. After data 
acquisition, blood for determination of plasma catecholamine 
ined (n = 9); subject 
, and heart rate and 
allowed to retilrn to baseline. 
hrine infusion was then begun 
ased to 50 @kg body weight 
per min. This infusion rate was used because it has been shown 
to result in elevation of the plasma epinephrine l vels similar 
to that achieved with moderate xercise (15), hypoglycemia 
(16) and acute myocardial infarction (17). After 10 min at the 
m~irna~ infusion rate to achieve a steady-state concentrat Ian 
(l&19), 5-min KG recordings were obtained in triplicate. The 
infusion was then stopped, and heart rate and blood pressure 
were allowed to return to baseline values. 
~~o~roterel~ol iiafitsion. lsoproterenol infusion was then 
started at 2 @min and gradually increased to 50 n per 
min. This infusion rate ‘as maintained for 10 min t ieve 
steady state because it has previously been shown (20) that at 
least 00% of the heart rate increase during isoproterenol 
infusion was achieved by 8 min. 0nc subject did not tolerate 
the maximal dose, and recordings were made at a reduced ose 
of 25 @kg per min. During the infusion, ECG recordings were 
made in triplicate. The infusion was then stopped, and time 
was allowed for heart rate and blood pressure to return to 
baseline values. 
Exercise. Subjects then performed symptom-limited xer- 
cise on a bicycle ergometer with progressively increasing work 
loads, starting at 150 to 300 kpond-m/min (corresponding to
-25 to 50 W) and increasing by 150 to 300 kpond-mlmin every 
2 min. All subjects exercised to fatigue (mean exercise time 
8.4 + 2.4 min), achieving a mean maximal heart rate of 168 2 
12 beatslmin (range 150 to 170). After return to the supine 
position and a 2-min recovery period, recordings were ob- 
tained in triplicate. A rest period was allowed for heart rate 
ressure to return to baseline values. 
Beta-adrenetgic blockade. Propranolol was ad- 
ministered intravenously ata rate of 1 mglmin in the supine 
position to a total dose of 0.2 mglkg (14). After the infusion 
was completed, three recordings were obtained. 
Beta-adrenergic and parasympathetic blockade (double block- 
ade). Atropine (0.04 mglkg) was then administered intrave- 
nously over 2 min in the presence of beta-adrenergic blockade 
Three recordings were then obtained. 
cart rate variability analysis. With a template-matchiug 
algorithm, an interval tachogram was generated for each 
recording. All 5-min recordings were visually examined and 
manually overread to verify beat classification. Nonsinus beats 
were eliminated along with one RR interval after the ectopic 
interval. Missing data were filled using a linear predictive 
model that incorporates the 20 preceding “ ood” data points. 
If there were not enough preceding ood intervals, data after 
the missing interval were used instead. The standard eviation 
of the RR intervals contained in each 5-min segment and the 
root mean square of the successive RR interval differences 
were calculated for each 5-min recording. The standard evi- 
ation is highly correlated with the total power (which is equal 
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to the total variance). Because of the short duration of the 
recordings, anautoregressive model (5) was used to generate 
heart rate spectra for each 5-min recording. The following 
frequency domain indexes ofheart rate variability were calcu- 
lated: 
1. 
2. 
3. 
4. 
5, 
power in the low frequency band from 0.04 to 0.15 Hz, in 
(beats/mir#; 
power in the high frequency band from 0.15 to 0.40 Hz, in 
(beats/min)*; 
the low frequency/high frequency power atio; 
the fractional power contirined inthe low frequency band 
(percent low frequency equals low frequency/total power); 
and 
the fractional power contained inthe high frequency band 
(percent high frequency equals high frequency/total power). 
Although power in lower frequency ranges has been reported 
in other studies, the physiologic correlation ofvery low fre- 
quency power to parasympllthetic and sympathetic tone is not 
clearly established. Thus, as in other studies (3,4,6-g), we focus 
on the low and high frequency ranges as defined earlier. 
plasma ratecbolsmine levels, Blood samples were col- 
lected in heparinized tubes and placed on ice. After centrifu- 
gation at 4°C at 3,ooO rpm for 15 min, 2 ml of plasma was 
transferred to a tube containing 4 mg of reduced glutathionc as
a preservative and stored at -70°C for subsequent analysis. 
Catecholamine levels in plasma were assayed by liquid chro- 
matography with electrochemical detection. The method com- 
bined liquid-liquid extraction f catecholamines from plasma 
with reversed-phase chromatography incorporating a cation- 
exchange r agent (Plasma Catecholamine Kit, Bioanalytical 
Systems, Inc.) (21,22). For replicate determinations f a l&ml 
plasma sample containing 0.25 pm01 of epinephrine and 
1.6 pmol of norepincphrine, i traassay coetlicients of variation 
ely, and interassay coefficients of 
respectively. 
Bats am@sis, The reproducibility of RR intent& at each 
phase of the study was assessed to determine whether system- 
atic variation related to each intervention was present. Repro- 
ducibility was evaluated by calculating intraclass correlation 
coefficients using a one-way random effects analysis of variance 
model (23-25). The intraclass correlation coefficient s an 
assessment of the intrasubject variability of a measure and 
reflects its reproducibility. An intraclass correlation coefficient 
XI.8 indicates excellent reproducibility. Values between 0.6 
and 0.8 reflect good reproducibility. Values KO.6 indicate fair 
to poor reproducibility. 
During the baseline recordings, the intraclass correlation 
co@icient was excellent (0.99;). During epinephrine infusion, 
isoproterenol infusion, beta-adrenergic blockade and double 
blockade, the RR intervals were highly reproducible over the 
three recording periods, with intraclass correlation coefficients 
between 0.92 and 0.95. Because the RR intervals were stable 
for all of the aformentioned conditions over the multiple 
recoding periods, for purposes of analysis the heart rate 
t 
IW = isoprotercnol; @ = beta-adrcnergic blockade; ~~~t~~pin~ = corn- 
bined b&a-;lcirenergic and pmsympathctic blockade with atrophic. 
variability data for each condition were averaged. Theintra- 
class correlation coefficient using all three RR interval record- 
ings during tilt was 0.72, which was significantly lower tban 
thrse for the other conditions. However, the intraclass corre- 
lation coefficient for the two recordings made at 10 and 15 min 
of tilt was 0.92, indicating that a stable RR interval was not 
obtained until the last wo recordings. Thus. only data from the 
last two recordings were averaged for analysis. Finally, the 
intraclass correlatioa co for the three postexercise 
period RR intervals als strated less reproducibility 
(0.67), and therefore only the initial 5-min postexercise record- 
ing was used for analysis. 
Time and frequency domain measures during each condi- 
tion are presented as the mean value ?JZ SD. The frequency 
domain heart rate variability data were also analyzed after 
logarithmic transformation. Because there was no difference in 
the results whether alogarithmic transformation was applied 
or not, the nontransformed data are presented. Differences in 
means between conditions were assessed using a 
analysis ofvariance with repeated measures; the 
method was used to adjust for multiple comparisons and 
calculation f 95% confidence intervals. Heart rate variability 
variables were compared between the following conditions: 
baseline versus tilt, epinephrine fusion, isoproterenol infu- 
sion, exercise, beta-adrenergic blo kade and double blockade. 
All tests are two-tailed; p < 0.05 was considered s 
significant. 
Results 
Figure 1 demonstrates he mean RR intervals recorded 
during each condition. Tilt, epinephrine infusion, isoprotere- 
no1 infusion and exercise r sulted in significant decreases in 
the RR intervals from 981 + 139 ms at baseline to 693 + 62, 
762 + 120,489 &32 and 437 2 79 ms, respectively, consistent 
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Baseline Exercise 
ure 2. Results of time domain heart rate variability (MRV) analysis 
rating the standard deviation (XI) and root mean square succes- 
interval ditkrcnccs (h&SD) for eitch study condition (theaa -C 
with their beta-adrencrgic effects. A similar dqrec of 
with double blockade (598 I!I 
condition on mean blood pressure is also shown in Figure 1. 
Blood pressure was significantly elevated from baseline only 
after exercise. 
eart rate variability. Effects qf betn-ndrmergic stitinnrhtion. 
The time domain measures of heart rate variability decreased 
consistently with all four sympathetic stimulation conditions 
(Fig. 2 and 3). During tilt, the standard eviation and root- 
mean-square successive difference decreased significantly from 
70.8 f 27.2 and 65.2 + 43.4 ms at baseline to 47.9 + 17 9 and 
21.2 2 10.7 ms, respectively. During epinephrine i fusion, the 
standard eviation and root-mean-square successive difference 
decreased significantly from baseline to 45.1 + 22.2 and 33.6 -C 
24.9 ms, respectively. During isoproterenol infusion, the stan- 
Figure 3. Change in time domain heart rate variability variables from 
baseline for each study condition. Error bars indicate 95% confidence 
iniervais. Aii changes noted are significant because the error bars do 
not cross the zero line. Abbreviations as in Figure 2. 
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Baseline Tilt Epinep~ri~e ko ibmcise 
108.5 
gure 4. Results of power spectral an 
D) in the low (LF) and high 
ition. bpm2 = (beatdmin)‘; 
demonstra&! the power 
frequency ba1i.k for each 
daix! ~~e~/~~t~on illld root-mean-square successive differc,lcc 
gnificantly from baseline to 17.1 J- 5.2 and 5.6 I 
ctively. lu the 5 min after exercise, the stan 
dcviat~o~ and root-~~eail~square successive difference de- 
creased signi~cantly from baseline to 28.8 ‘-c 8.2 and 11.2 -c 
11.2 ms, respectively. The changes in standard eviation and 
root-mean-square successive difference from baseline (with 
95% confidence intervals) induced by beta-adrenergic stimu- 
lation are shown in Figure 3. 
The effects of these maneuvers on the frequency domain 
measures of heart rate variability were diverse, depending on 
the mode of stimulation (Fig. 4 to 7). During tilt, low frequency 
power increased significantly from 3.24 -+ 2.50 (beats/min)* at 
baseline to 7.41 + 4.92 (beats/min)‘, with no significant change 
in the fractional power (32.5 i: 10.3% at baseline; 38.1 + 5.0% 
during tilt). During epinephrine i fusion, there were no signif- 
icant changes from baseline in either low-frequency power 
(3.77 + 3.01 (beats/min)‘) or fractiorral power (33.1 L 9.0%). 
During isoproterenol infusion, there was no significant change 
in low frequency power (2.37 It_ 1.57 (beats/min)*), but there 
was a significant decrease in fractional power from baseline to 
23.6 k 8.9%. After exercise, there was a mild but insignificant 
decrease in low frequency power (1.92 + 0.78 (beats/min)*), 
associated with a significant decrease in fractional power to 
Figure 5. Results of power spectral analysis demonstrating the percent 
power (mean + SD) in the low and high frequency bands for each 
study condition. Abbreviations as in Figure 4. 
50 
Tilt kpinephrlne Iso Exercise 
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cr spectral analysis demonstrating the ratio of 
in the low and high frequency bands for each 
study condition. Abbreviations as in Figure 4. 
20.9 LIZ 9.7% Thus, isapraterenol and exercise had similar 
&xts on low frequency power, which were different from 
those seen with both tilt and epinephrinc infusion. 
During tilt, there was a mild but insignificant decrease in 
high frequency power from 2.24 ?z 1.85 (beatslmin)” at base- 
line to 1.64 Z?I 1.42 (beatslmin)’ and a significant decrease in 
fractional high-frequency power from 21.9 + 10.7% to 8.1 -t 
4.6%. Epinephrine infusion was not associated with a signifi- 
cant change in either high-frequency power (1.98 + 2.05 
(beatslmin)‘) or fractional power (16.4 2 7.5%). During 
isoproterenol infusion, there were significant decreases in the 
high frequency power to 0.76 +‘ 0.75 (beatslmin)” and in 
fractional power to 6.7 ?z 4.6%. After exercise, there were also 
significant decreases in both high frequency power to 0.79 L 
0.63 (beatslminy and fractional power to 6.7 2 4.6%. Again, 
isoproterenol and exercise produced similar patterns that were 
different than those produced by both tilt and epinephrinc 
infusion. 
The ratio of low to high frequency power increased signif- 
icantly from 1.98 t 1.35 at baseline to 6.34 C 330 during tilt. 
During epinephrine infusion, there was no significant change 
in the ratio of low to high frequency power (2.56 It 1.27). 
Isoproterenol infusion was associated with a significant in- 
crease in the ratio of low to high frequency power to 5.07 it 
3.05. After exercise, there was no significant change in the ratio 
of low to high frequency power (3.46 -C 1.98). The changes in 
the frequency domain variables from baseline {with 95% 
confidence intervals) induced by beta-adrenergic stimulation 
are shown in Figure 7. 
and combined betasdrPn~~~~~msr,npathcric 
er Intravenous administration of propranolol, there 
was no signiiicant change in standard deviation (61.5 2 25.2 ms) 
or root-mean-square successive difference (53.2 -C 34.6 ms). Low 
ncy power (2.94 2 1.41 (beatslmin)‘), high frequency 
r (2.16 * 1.93 (beats!min)‘) and fractional low and high 
frequency powers (34 2 8% and 22 2 14%, respectively) were 
unchanged f&n b&ine, as was the ratio of low to high 
h&wty (3.00 2 2.67). With double blakade, there were 
ecfeases in both the standard deviation and root- 
mean-Square successive difference from baseline to 5.5 + 2.4 and 
LF 
Exercise 
IS0 
Eplncphrlnc 
Tilt 
.6 -4 0 2 4 6 
CHANGE FROM BASELINE (bpm2) 
%LF 
Exe& 
Epinephrine 
-_Ds____ Tilt 
CHANGE FROhl BASELINF. 
LFMiF 
Ercrdst 
Is0 
I I I * I 
p:, , , 
-10 -8 -6 -0 -2 0 2 4 6 8 10 
CHANGE FROM BASELINE 
Epinepluine 
Tut 
Figure 7. Change in the frequency-domain heart rate variability variables 
from baseline for each study condition. Error bars indicate 95% confi- 
dence intervals, When error bars cross the zeam line, the changes noted are 
not significant. A, Changes in low and high frequency power. Ii, Changes 
in percent low and high frequency power. C, Changes in low to high 
kquency power ratio. Abbreviations as in Figure 4. 
2.5 ? 2.7 ms, respectively. There were marked reductions in low 
and high frequency powers to 0.06 2 0.05 (beatslmin)’ (11.4 + 
6.3%) and 0.07 ? 0.10 @eats/min)2 (13.8 t llS%), respectively. 
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I(987 
ty Variables for Each of the with higher intraclass correlation toe 
cients than the fr power, which frequently derno~~ 
Recording (mean 2 SD) ility. 
I 2 3 4 
SD (msl 64.6 + 28.2 74.1 ? 3s.4 6Y.4 + 25.8 6Y.8 -t 27.5 
MSSD (ms) 62.4 2 44.2 6Y.2 2 52.1 61.6 2 40.8 6Q.8 I 43.7 
LF ([beats/min]‘) 3.2 2 2.1 3.5 2 2.9 3.3 c 2.8 3.6 2 3.2 
HF (@Wmin]‘) 2.3 2 1.8 2.5 + 2.1 2.3 2 2.2 2.2 -+ l.Y 
%LF 36.4 2 11.7 31.4 It: 12.5 31.2 2 12.1 34.2 + 14.0 
%HF 23.2 2 10.7 20.7 2 13.5 21.1 2 12.2 1.7 2 14.0 
LFMF 1.9? 1.2 2.0 5 1.8 2.0 -c1.1 2.4 2 2.1 
SD, MSSD = time domain indexes of heart rate variability (see text); LF, 
HF = power in the low and high frequency bands, respectively (see text); %LF, 
F = percent of the total power in the low and high frequency bands, 
respectively; LF/HF = lIlti of low lo high frequracy power. 
The ratio of low to high frequency power is di~~~lt to interpret 
after double blockade b cause of the minimal residual power in 
those frequency bands. 
e Iwels. 
epinephrine l vels were 0.60 + 0.41 and 1.34 + 0.77 pmol/ml, 
respectively. With tilt, there was no significant change in the 
epinephrine l vel (Q.66 2 0.44 pmol/ml); however, the norepi- 
increased to 3.56 + pmol/ml. 
iiity of heart rate va lily variables. Table 1 
demonstrates the mean values for the heart rate variability 
indexes for each of the four baseline recordings. By analysis of 
variance, there were no significant changes in the group mean 
values. The intrasubject reproducibility of these variables was 
calculated for each condition (Table 2). The intraclass corre- 
lation coefficients are not reported for double blockade or 
isoproterenol infusion because the intersubject variability dur- 
ing these conditions was markedly attenuated. Intraclass cor- 
relation coefficients are also not reported for exercise because 
only one recording was analyzed for that condition. The 
intraclass correlation coefficients for the time domain mea- 
sures of heart rate variability were excellent, varying from 0.80 
to 0.96. Overall, the frequency domain measures of heart rate 
variability were less reproducible than the time domain mea- 
sures. High frequency power was the most reproducible mea- 
surement, with intraclass correlation coefficients varying from 
0.72 to 0.91, and the absohl’ power within each frequency 
Table 2. lntraclass Correlation Coefficients for the Measured Heart 
Rate Variabilitv Variables Durinrr Various Study Conditions 
Beta- 
Baseline Tilt Epinephrine Blockade 
SD 0.85 0.80 0.89 0.86 
MSSD 0.96 0.80 0.95 0.86 
LF 0.71 0.63 0.78 0.76 
HF 0.87 0.72 0.91 0.90 
%LF 0.53 0.58 0.40 0.34 
%HF 0.70 0.71 0.56 0.80 
LFMF 0.65 0.45 0.54 0.87 
Abbreviations as in Table 1. 
This study explored bysiologic and pharma- 
cologic sympathetic stimuli on heart rate variability in a group 
of normal healthy subjects, using currently accepted time and 
frequency domain indexes of heart rate variability. Our find- 
ings suggest that beta-adrenergic stimulation leads to a consis- 
tent decrease in the time domain measures of heart rate 
variability, but frequency domain indexes how variable re- 
sponses depending on the stimulus. Although tilt causes a 
significant increase in low frequency power and the ratio of low 
to high frequency power, these changes were not noted in all 
the other conditions of beta-adrenergic stimulation. These 
gildings suggest that the heart rate variability response to 
sympathetic stimulation may differ depending on the type of 
stimulus. Studies that utilize heart rate variability to quantify 
“ sy ed to take this into account. 
nergic ~ti~M~at~~~. Timedomain mea- 
sures of heart rate variability hav: been traditionally used as 
indexes of parasympathetic tone (1). Although sympathetic 
stimulation may be associated with parasympathetic witb- 
drawal, isoproterenol i fusion has been shown to be associated 
ith an increase in vagal tone (26). Thus, the consistent 
ecrease in the time domain measures of heart rate variability 
noted in the present study with all four sympathetic stimuli 
cannot be attributed solely to a decrease in parasympathetic 
tone. This implies that low heart rate variability as measured by 
the time domain variables may indicate ither low parasympa- 
thetic tone or heightened sympathetic tone. These indexes are 
therefore not specific markers of parasympathetic tone. 
The low frequency component of the heart rate spectrum 
has been shown to be affected by both the sympathetic and 
parasympathetic nervous ystems (4,5,7,9,27). Several investi- 
gators (4,9,27,28) have demonstrated that augmentation of
sympathetic tone by maneuvers, uch as standing, tilting, 
exercise and mental stress, results in an increase in the power 
contained in this low frequency peak. This has led to the use of 
the low frequency power/high frequency power ratio or frac- 
tional low frequency power as an index of sympathetic tone 
(2,4,5,7,29). Disease states such as congestive heart failure and 
myocardial infarction, in which heart rate variability analysis 
has been applied, may be associated with elevated levels Of 
sympathetic neural discharge and circulating catecholamines 
(17,30). To date, there has been no attempt to evaluate the 
effects of circulating catecholamines on heart rate variability 
despite the application of this technique to situations where 
elevated levels of circulating catecholamines are observed. 
Epinephrine infusion was therefore studied because it is an 
endogenous catecholamine, and an infusion rate was chosen 
that matches levels observed uring moderate xercise (15) 
and acute myocardial infarction (17). Isoproterenol Was also 
tested because it is a pure beta-adrenergic agonist. Upright tilt 
1088 AHMED ET AL. 
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is a well known maneuver that augments ympathetic tone. The 
increase in sympathetic tone during tilt was documented in OUT 
subjects by an increase in the plasma norepinephrine levels. 
The absence of an increase in plasma epinephrine levels 
suggests hat the increase in sympathetic tone occurs predom- 
inantlyby sympathetic neural stimulation. Finally, exercise may 
augment both sympathetic neural discharge and circulating 
catecholamines (3132). 
Because alpha-adrenergic tone does not contribute signifi- 
an@ to heart rate variability (33), the effects of tilt, isopro- 
terenol infusion, cpincphrine infusion and excrcisc on heart 
rate variability are mcdiatcd by means of changes in beta- 
stimulation or parasympathetic tone, or both. If 
heart rate variability analysis can “measure” sympathetic tone. 
a consistent change in the variable being investigated should be 
noted. The low frequency power was noted to incrcn.sc with tilt. 
as has been shown previously (4,s). However, the low frc- 
quency power did not incrcasc significantly with any of the 
other conditions. In fact, thcrc was a mild dccrcasc in low 
frequency power with isoprotcrcnol infusion and after excrcisc 
that led to a significant decrease in fractional low frequency 
power rhwrded during these conditions. A decrease in frac- 
tionul low frequency power with exercise has been previously 
reported (.W). The ratio of low to high frequency power was 
significantly increased with tilt and isoproterenol infusion but 
did not increase significantly during epincphrinc infusion or 
after exercise. This suggests that the physiologic response of 
the sinus node to these other sympa:hctic stimuli does not 
occur with phasic changes in the low frequency range. Consc- 
quently, neither low frequency power, fI?lCtiOnid kow frequency 
power nor the ratio of low to high frequency power can bc used 
as a general index of sympathetic tone that includes both 
sympathetic neural effects and those cau.scd by &culating beta- 
agonists. 
Thcrc urc several potential explanations for our findings. 
First, the characteristics of the sympathetic stimulation 
achieved by tilt, exercise, isoproterenal infusion and epineph- 
rinc infusion are different. That is, the rclativc contributions of 
symp@thetic neUtd discharge versus effects of circulating cat- 
echolamines vary with the different modes of sympathetic 
stimulation, and each component may have its own signature 
on the heurt rute variability power spectrum. In addition, the 
interaction of pamsympathetic tone with each of these condi- 
tions may bc diffcrcnt and may affect the power spectrum. 
AhhouBh attempts to correct for parasympathetic tone by 
using the ratio of low to high frequency power or the fractional 
law frequency power have hcen propoxd, thcsc variables did 
not wppcar to adjust for potential differences in parasympa- 
thetic: tone that accompanied the different sympathetic stimuli 
aad combined beta-adrenergic 
e. In the present study, acute 
betadane@ blockade with propranolol in the supine state 
at rest had no significant effect on heart rate variability, as has 
P*s& been reported (4,9). However, Coker et al. (35) 
found an increase in heart rate variability with atenolol admin- 
istration. Similarly, other investigators (4,36,37) have foun 
increases in heart rate variability with long-term administration 
of beta-adrenergic blockers. Thus, the type of beta-blocker as 
well as duration of administration may affect the observed 
changes in heart rate variability. As sxpected, combined hcta- 
adrcnergic and p~~rasympatiietic blockade markedly reduce 
heart rate variability (5,9). 
Rep~uc~bil~~. Because our recordings were performed 
in triplicate, we were able to charactcrizc the reprodMcibi~ity of 
our results. To ensure stability of each condition, the intraclass 
correlation coellicicnts for the RR intervals were calcalatcd for 
each condition. As cx~ctcd, ~~lci~s~rc~~cnts duri~~g the rccov- 
cry pha,sc of exrrcisr wcrc not constant over the 15min 
recording pcritd. Surprisingly, the recordings 
also changed over the IS-min recording pcrio 
ings wcrc not bcgun until ilfk!r S mitl of till. ~~~mil~ilti(~~ of the 
intraclass correlation cocllicient for the final two recordings 
dcmonstratcd cxccllcut rcpr~~dl:cil~ility. Thus, a steady state is 
not achieved by 5 min after initiation of the tilt; by 10 min, 
steady state Wits noted. This has im~)rtil~t pr;lcticitl implicit- 
tions for the many investigators (4,38--4(l) examining tbc 
changes in autonomic tone induced by tilt with heart rate 
variability analysis. All other conditions tcstcd dcmonstratcd 
cxccllcnt stability. 
The time domain mcasurcs of heart rate variability detll~n- 
stratcd exccllcnt reproducibility. The rcproducil~iiity of thr 
frequency domain mcasurcs was variable. High frcqucncy 
power was the most rcproduciblc index, demonstrating mod- 
crate to cxccllcnt stability. Low frcqucncy power dcmonstratcd 
modcratc stability. ~r~!cti~~ni~~ low and high frcqucncy power as 
well as the ratio of low to high frcqucncy power were generally 
less reproducible. Although Pagani et al. (4) rcportcd no 
chaugc in the mean data for a subpopulation of IO patients in 
their study, the intrasubjcct variability was not rcportcd. Ex- 
amination of the mean data from each of our multiple record- 
ings also reveals no significant change for the group (Table I), 
yet the reproducibility for the individual subjects is quite 
variable, as measured by the intraclass correlation cocflicients 
(Table 2). 
Study limitations. Many conditions were tested in this 
study. The order of testing was specifically chosen so that the 
testing could bc completed with a return to baseline heart rate 
and blood pressure between conditions. Although it is possible 
that there was a cumulative effect from the various conditions, 
the magnitude of such an effect is likely very small, because 
testing for each condition was only begun when the subject’s 
heart rate and Mood prcssurc had returned to baseline values. 
The studies typically lasted 5 to 7 h to allow for this. 
Implications. Heart rate variability analysis has been ap- 
plied clinically either as a “measure” of autonomic tone in a 
variety of disease states (40-44) or as a prognostic index 
(45,46). The results of the present study suggest hat current 
concepts with regard to the ability of heart rate variability to 
“measure” autonomic tone may need to be reassessed. For 
example, several investigators (11-13) have inferred that the 
decrease in time domain measures of heart rate variability or 
owever. 
ings is lhnt the obscrvcd 
congestive heart failure may be KdiWd to a rest increase in 
sympathetic tone that improves with therapy. 
~X~hi~tiOil is supportd by the observation t 
deviation is closely COrdikted (negatively) wi 
~i~t~i~)e~cit~~ti~~n noted in congestive heart faibu-c (47). 
WiiS ht have been invesliga?ted with heart rate 
ysis iucli~dc myocarilial infarction (4X), effects of 
drug therapy (49), suddcu cardiac death (SO), V~t~t~~~~I~~ 
tilc~lyci~rdji~ (51 ), diabetic ncuropathy (40) and vasodeprcssor 
SYIICO~C ($2). Interpretation of results obtained in those stud- 
~CS OIity 1~ signil~c~~li~ly altcred by OUT findings. 
The uSc of hrt ri\lC ViWiiIhility idySiS For ilSSl2WllCIII 01 
prognosis dots not I riori assumptions iIhOUt Ilic 
COWAiltiOll Of tk cr;~limis iI1 i~UlO- 
nomic tone. Thus, t Nt i!llpiKt 011 thC 
investigations that have found heart rate variability to be of 
prognostic value in patients after myocardial infarction (45,4(,). 
~~~~~Msi~rn~. Currently used methods of heart rate vari- 
ability analysis are not specitic for mcasuremcnt of sympalhetic 
tone, defined as both sympathetic neural stimulation and 
effects of circulating beta-adrenergic agonists. Further studies 
will be rcquircd to evaluate whether the techniques of heart 
rate variability analysis can be modified to overcome these 
problems. 
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